These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34865544)

  • 21. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Just allocation of COVID-19 vaccines.
    Herlitz A; Lederman Z; Miller J; Fleurbaey M; Venkatapuram S; Atuire C; Eckenwiler L; Hassoun N
    BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33589419
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid evolution of the COVID-19 pandemic calls for a unified public health response.
    He N
    Biosci Trends; 2021 Sep; 15(4):196-200. PubMed ID: 34193749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equitable and Effective Distribution of the COVID-19 Vaccines - A Scientific and Moral Obligation.
    Binagwaho A; Mathewos K; Davis S
    Int J Health Policy Manag; 2022 Feb; 11(2):100-102. PubMed ID: 33949818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Public health ethics and the COVID-19 pandemic.
    Aliyu AA
    Ann Afr Med; 2021; 20(3):157-163. PubMed ID: 34558443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine access, equity and justice: COVID-19 vaccines and vaccination.
    Privor-Dumm L; Excler JL; Gilbert S; Abdool Karim SS; Hotez PJ; Thompson D; Kim JH
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37290896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic.
    Altindis E
    Expert Rev Vaccines; 2022 Apr; 21(4):427-430. PubMed ID: 34878957
    [No Abstract]   [Full Text] [Related]  

  • 29. The commitment for fair distribution of COVID-19 vaccine among all countries of the world.
    Sadeghi R; Masoudi MR; Khanjani N
    Res Nurs Health; 2021 Apr; 44(2):266-267. PubMed ID: 33522613
    [No Abstract]   [Full Text] [Related]  

  • 30. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rethinking the Principle of Justice for Marginalized Populations During COVID-19.
    Ashworth H; Soled D; Morse M
    J Law Med Ethics; 2021; 49(4):611-621. PubMed ID: 35006052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competing Responses to Global Inequalities in Access to COVID Vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
    Sparke M; Levy O
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S86-S92. PubMed ID: 35535787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards a new model of global health justice: the case of COVID-19 vaccines.
    Jecker NS; Atuire CA; Bull SJ
    J Med Ethics; 2023 May; 49(5):367-374. PubMed ID: 35487676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine.
    Sekalala S; Forman L; Hodgson T; Mulumba M; Namyalo-Ganafa H; Meier BM
    BMJ Glob Health; 2021 Jul; 6(7):. PubMed ID: 34253631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uneven power dynamics must be levelled in COVID-19 vaccines access and distribution.
    Alaran AJ; Adebisi YA; Badmos A; Khalid-Salako F; Gaya SK; Ilesanmi EB; Olaoye DQ; Bamisaiye A; Lucero-Prisno DE
    Public Health Pract (Oxf); 2021 Nov; 2():100096. PubMed ID: 33615282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2: Unique Challenges of the Virus and Vaccines.
    Mahmoodpoor A; Sanaie S; Samadi P; Yousefi M; Nader ND
    Immunol Invest; 2021 Oct; 50(7):802-809. PubMed ID: 34109900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An intersectional human rights approach to prioritising access to COVID-19 vaccines.
    Sekalala S; Perehudoff K; Parker M; Forman L; Rawson B; Smith M
    BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33627362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic.
    Guidry JPD; Perrin PB; Laestadius LI; Vraga EK; Miller CA; Fuemmeler BF; Burton CW; Ryan M; Carlyle KE
    Vaccine; 2021 Apr; 39(17):2452-2457. PubMed ID: 33745729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.